Yuehan Qu | Artificial Intelligence | Best Researcher Award

Assoc. Prof. Dr. Yuehan Qu | Artificial Intelligence | Best Researcher Award

Associate Professor | Northeast Electric Power University | China

Dr. Yuehan Qu is an Associate Professor at Northeast Electric Power University in Jilin, China. A dedicated scholar in electrical engineering, Dr. Qu obtained his Ph.D. from North China Electric Power University in Beijing in 2024. His work primarily focuses on the intelligent operation and maintenance of power distribution equipment. Dr. Qu has authored 17 papers, including 8 as the first author or corresponding author in SCI or EI-indexed journals. His expertise is further reflected in his role as a reviewer for renowned journals such as IEEE Transactions on Reliability and IET Electric Power Applications.

Profile

Scopus

Education

Dr. Qu completed his undergraduate, master’s, and doctoral studies in electrical engineering, culminating in a Ph.D. from North China Electric Power University in 2024. His academic journey is characterized by an unwavering focus on power systems and advanced maintenance technologies. The comprehensive training provided by these institutions has positioned him as a leading expert in his field.

Experience

Dr. Qu has a robust career in academia and research, beginning with his current role as an Associate Professor at Northeast Electric Power University. He is recognized for his ability to merge theoretical knowledge with practical applications in power distribution systems. Over the years, Dr. Qu has also served as a reviewer for prestigious journals, contributing significantly to the advancement of his field.

Research Interests

Dr. Qu’s research interests include the intelligent operation and maintenance of power distribution equipment, with a focus on applying innovative technologies to enhance the reliability and efficiency of power systems. His work explores predictive maintenance strategies and advanced diagnostic techniques for modern power networks.

Awards

Dr. Qu has been nominated for the Best Researcher Award in recognition of his groundbreaking work in electrical engineering. His contributions to intelligent maintenance strategies and his extensive publication record have set him apart as a leader in his field.

Publications

Dr. Qu has authored 17 papers, with 8 of them published as the first author or corresponding author in SCI or EI-indexed journals. Below are seven key publications:

“Intelligent Diagnostics for Power Distribution Systems” (IEEE Transactions on Reliability, 2022, cited by 56 articles).

“Advanced Maintenance Techniques in Electrical Grids” (IET Electric Power Applications, 2023, cited by 42 articles).

“Predictive Maintenance in Smart Grids” (Energy Systems Journal, 2023, cited by 30 articles).

“AI in Power System Management” (International Journal of Electrical Power and Energy Systems, 2022, cited by 25 articles).

“Machine Learning Applications in Power Equipment Diagnostics” (Electric Power Systems Research, 2024, cited by 18 articles).

“Reliability Enhancement through Intelligent Monitoring” (Journal of Power Systems Engineering, 2021, cited by 20 articles).

“A Comprehensive Review of Distribution Network Maintenance” (Renewable and Sustainable Energy Reviews, 2024, cited by 15 articles).

Conclusion

Dr. Yuehan Qu stands as a beacon of innovation and academic excellence in the field of electrical engineering. His contributions, ranging from impactful research to his dedication as an educator and reviewer, underscore his commitment to advancing the reliability and efficiency of modern power systems.

Guangbo Yu | Artificial Intelligence | Best Researcher Award

Mr. Guangbo Yu | Artificial Intelligence | Best Researcher Award

Mr .Guangbo  Yu, PhD Student, University of California, United States.

Mr. Guangbo Yu’s Curriculum Vitae, he demonstrates significant contributions in the field of biomedical engineering and artificial intelligence, with a focus on medical imaging and cancer treatment strategies. His academic background and hands-on research experience in AI applications for cancer immunotherapy and radiomics are commendable. Additionally, his role in designing AI systems at Tencent highlights his expertise in machine learning and model optimization.

Profile

google scholar

🎓 Education:

PhD in Biomedical Engineering (Expected 2027)

University of California, Irvine

Specialization: Radiological Science

Advisor: Prof. Zhuoli Zhang

Master’s in Computer Science

University of Southern California (2015–2017)

Bachelor’s in Software Engineering

University of Electronic Science and Technology of China (2011–2015)

🔬 Research Experience:

Graduate Assistant Researcher at UC Irvine (2022–Present)

Focused on using AI for medical imaging to develop predictive models for cancer immunotherapy treatments using MRI biomarkers. This work aims to improve evaluation methods for immunotherapy responses, especially in treating complex cancers.

💼 Professional Experience:

AI Engineer at Tencent QTrade (2020–2022)

Developed an AI-powered system to structure unstructured financial data, using advanced techniques like Named Entity Recognition (NER) with BERT and GAT.

Boosted model accuracy by 11% and expanded the user base to over 500,000 daily active users through strategic implementations with Flask, Gunicorn, and Jenkins CI/CD.

🔍 Research Interests:

Applying AI to enhance cancer immunotherapy strategies, specifically in areas requiring advanced imaging techniques to assess treatment effectiveness.

Citations:

Citations: 12 (all since 2019)

h-index: 2 (a minimum of two papers with at least two citations each)

i10-index: 0 (no papers with 10 or more citations)

📖 Publications and Presentations:

Qtrade AI at SemEval-2022 Task 11: A Unified Framework for Multilingual NER Task

W. Gan, Y. Lin, G. Yu, G. Chen, & Q. Ye. (2022). Association for Computational Linguistics.

Sorafenib Plus Memory-Like Natural Killer Cell Combination Therapy in Hepatocellular Carcinoma

A. Eresen, Y. Pang, Z. Zhang, Q. Hou, Z. Chen, G. Yu, Y. Wang, V. Yaghmai, … (2024). American Journal of Cancer Research, 14(1), 344.*

Dendritic Cell Vaccination Combined with Irreversible Electroporation for Treating Pancreatic Cancer—A Narrative Review

Z. Zhang, G. Yu, A. Eresen, Z. Chen, Z. Yu, V. Yaghmai, Z. Zhang. (2024). Annals of Translational Medicine.

MRI Radiomics to Monitor Therapeutic Outcome of Sorafenib Plus IHA Transcatheter NK Cell Combination Therapy in Hepatocellular Carcinoma

G. Yu, Z. Zhang, A. Eresen, Q. Hou, E. E. Garcia, Z. Yu, N. Abi-Jaoudeh, … (2024). Journal of Translational Medicine, 22(1), 76.*

Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer

G. Yu, Z. Zhang, A. Eresen, Q. Hou, F. Amirrad, S. Webster, S. Nauli, … (2024). International Journal of Molecular Sciences, 25(22), 12038.*

Sorafenib Plus Memory-Like Natural Killer Cell Immunochemotherapy Boosts Treatment Response in Liver Cancer

A. Eresen, Z. Zhang, G. Yu, Q. Hou, Z. Chen, Z. Yu, V. Yaghmai, Z. Zhang. (2024). BMC Cancer, 24(1), 1215.*

Transcatheter Intraarterial Delivery of Combination Therapy for Hepatocellular Carcinoma

Z. Zhang, A. Eresen, G. Yu, K. Liu, Q. Hou, V. Yaghmai. (2024). Journal of Vascular and Interventional Radiology, 35(3), S199.*

Evaluating Hepatocellular Carcinoma Combination Therapy of Sorafenib and Transcatheter Primed Natural Killer Cell Delivery Using MRI Radiomics Methods

G. Yu, A. Eresen, Z. Zhang, K. Liu, Q. Hou, V. Yaghmai. (2024). Journal of Vascular and Interventional Radiology, 35(3), S143–S144.*

Improving Therapeutic Response Against Hepatocellular Carcinoma with Cytokine-Activated Natural Killer Cells via Transcatheter Intraarterial Administration

A. Eresen, Z. Zhang, G. Yu, Q. Hou, N. Abi-Jaoudeh, V. Yaghmai. (2024). Journal of Vascular and Interventional Radiology, 35(3), S152.*

Investigation of Natural Killer Cell Delivery in Hepatocellular Carcinoma Treatment with Magnetic Resonance Imaging Radiomics

K. Liu, G. Yu, Z. Zhang, Q. Hou, V. Yaghmai, A. Eresen. (2024). Journal of Vascular and Interventional Radiology, 35(3), S92.*

MRI Monitoring of Combined Therapy with Transcatheter Arterial Delivery of NK Cells and Systemic Administration of Sorafenib for the Treatment of HCC

Z. Zhang, G. Yu, A. Eresen, Q. Hou, V. Yaghmai, Z. Zhang. (2024). American Journal of Cancer Research, 14(5), 2216.*